ArticleBlood vessels, thrombosis & hemostasis2025

Elevated tissue factor pathway inhibitor delays thrombin generation in COVID-19 but is not associated with clinical outcomes.

Alicia S Eustes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.